T

    Transcode Therapeutics Inc (RNAZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.10
    -0.08 (-3.67%)

    Market Cap: $2.31M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(8/16)
    Avg Surprise
    -204.88%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$-7.17N/AN/ABeat-39.8%
    Mar 26
    		$-21.28N/AN/ABeat+98.3%
    Dec 25
    		$-16.42N/AN/ABeat+98.7%
    Sep 25
    		$-5.82$-1.02-470.59%Miss+96.1%
    Jun 25
    		$-5.13$-1.64-212.80%Miss+100.0%
    Mar 25
    		$-1286.15$-89.88-1330.96%Miss-114.1%
    Dec 24
    		$-1286.15$-89.88-1330.96%Miss-105.0%
    Sep 24
    		$-147.84N/A+67.35%Beat+99.8%
    Jun 24
    		$-27350.42$-21436.81-27.59%Miss+77.5%
    Mar 24
    		$-600.60N/A+97.68%Beat-157952.6%
    Dec 23
    		$-627.33$-356.40-76.02%Miss+99.8%
    Sep 23
    		$-62092.84$-55440.03-12.00%Miss+74.5%
    Jun 23
    		$-121598.47$-125294.48+2.95%Beat+54.3%
    Mar 23
    		$-0.38$-0.38+0.00%Beat-72.7%
    Dec 22
    		$-288288.17$-280896.17-2.63%Miss-69.6%
    Sep 22
    		$-243936.15$-295680.18+17.50%Beat-121967975.0%
    Jun 22
    		$-266112.16$-221760.13-20.00%Beat-52178954.9%
    Mar 22
    		$-0.22$-0.25+12.00%Beat-
    Dec 21
    		$-170016.10$-184800.11+8.00%Beat-
    Sep 21
    		$-0.20N/AN/ABeat-
    Jun 21
    		$0.51$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.04EV/EBITDA-0.59x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-59.30%ROIC157.50%
    Financial Health
    Debt/Equity-0.02xInterest CoverageN/A
    Current Ratio1.97xQuick Ratio1.97x
    Trading Statistics
    Beta1.24Avg Volume76.81K
    52-Week High$20.9952-Week Low$2.09

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.64
    SMA 20$3.20
    SMA 50$5.38
    SMA 200$7.57
    EMA 10$2.62
    EMA 20$3.30
    EMA 50$4.68
    EMA 200$8.65

    MACD

    Line: -0.92Signal: -0.91Hist: -0.00

    ADX

    ADX: 41.0+DI: 10.2-DI: 37.5

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$2.60

    Bollinger Bands

    Upper Band$4.63
    Lower Band$1.77
    %B Position8946%(Upper)
    Band Width0.12

    RSI (14-Day)

    Oversold
    20.9

    Momentum Oscillators

    Stoch %K7.0
    Stoch %D5.1
    Williams %R-85.6
    ROC (10d)-33.5%
    Momentum-1.06
    CCI (20d)-135.7
    MFI (14d)8.7

    Volatility Measures

    ATR (14d)$0.47(22.3%)
    StdDev (20d)0.72
    Hist Vol65.4%(High)

    Volume Flow

    VWAP$2.07
    OBV304.5M
    AD Line90.0B
    CMF (20d)-0.117

    Volume Metrics

    Avg Vol (20d)80.1K
    Vol Ratio10.4x(High)
    VWMA (20d)$2.54

    Pivot Points

    R3$2.58
    R2$2.46
    R1$2.32
    Pivot Point$2.21
    S1$2.06
    S2$1.95
    S3$1.81

    Advanced Oscillators

    TSI-48.93
    Ultimate Osc31.5
    KST-528.80

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0N/A$0$0$0$-284,482$0$0$0N/A$0
    Gross Profit$0$0N/A$0$0$0$284,482$0$0$0N/A$0
    Operating Expenses$6.79M$17.76M$16.03M$4.56M$4.22M$3.17M$5.09M$2.17M$5.11M$3.29M$4.10M$5.31M
    R&D$3.69M$15.53M$5.48M$3.16M$2.57M$2.22M$3.64M$1.23M$3.08M$1.76M$3.36M$3.34M
    SG&A$2.54M$2.22M$1.76M$1.40M$1.66M$951,652$1.45M$938,026$2.03M$1.53M$733,961$1.97M
    Operating Income$-6,789,505$-17,755,029$-16,026,558$-4,561,200$-4,221,134$-3,171,179$-5,092,387$-2,165,412$-5,113,916$-3,288,982$-4,097,587$-5,310,252
    Interest Income$52,168$91,888$78,757$147$148$146$159$179$178$168$138$131
    Interest Expense$0$0$542$5,960$0$114$1,833$10,792$4,482$9,706$17,345$17,282
    Income Before Tax$-6,749,828$-17,553,762$-13,217,042$-4,856,051$-4,276,502$-12,085,413$-5,915,958$-2,321,387$-5,190,814$-3,326,812$-4,087,546$-5,299,962
    Income Tax Expense$300$231,309$0$0$0$0$0$0$0$0$0$0
    Net Income$-6,750,128$-17,785,071$-13,443,110$-4,856,051$-4,276,502$-12,085,413$-5,915,958$-2,321,387$-5,190,814$-3,326,812$-4,087,546$-5,299,962
    EBITDA$-6,778,059$-17,621,714$-13,250,477$-4,845,457$-4,263,208$-12,034,271$-5,791,429$-2,183,253$-5,043,676$-3,175,627$-3,930,166$-5,144,028
    EBIT$-6,801,996$-17,645,650$-13,295,257$-4,850,238$-4,276,650$-12,085,445$-5,914,284$-2,310,774$-5,186,510$-3,317,274$-4,070,339$-5,282,811
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RNAZ

    News

    TransCode Therapeutics, Inc. (RNAZ) Stock Price, News, Quote & History

    This Yahoo Finance page provides a detailed overview of TransCode Therapeutics, Inc. (RNAZ), a clinical-stage biotechnology company focused on immuno-oncology and RNA therapeutics for cancer treatment. It includes real-time stock price data, historical performance, key financial metrics, company overview, and comparisons with similar biotechnology firms. The article highlights the company's therapeutic candidates and preclinical programs, along with its collaboration with The University of Texas M. D. Anderson Cancer Center.

    Yahoo! Finance Canada•8/8/26•
    Neutral

    Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV

    RedChip Companies will feature interviews with Virax Biolabs Group Ltd. (Nasdaq: VRAX) and Transcode Therapeutics Inc. (Nasdaq: RNAZ) on its "RedChip Small Stocks, Big Money™" show. The interviews will air on Bloomberg TV on Saturday, August 8th, at 7:00 p.m. ET, and on CNBC on Sunday, August 9th, at 11:00 a.m. ET. Both CEOs will discuss their companies' financial positions, strategic plans, and product development, including clinical trial progress and commercialization strategies.

    Corsicana Daily Sun•8/8/26•
    Bullish

    Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV

    RedChip Companies will feature interviews with Virax Biolabs Group Ltd. (Nasdaq: VRAX) and Transcode Therapeutics Inc. (Nasdaq: RNAZ) on its "RedChip Small Stocks, Big Money™" show. The interviews, discussing financial positions, strategic progress, and clinical advancements, are set to air on Bloomberg TV and CNBC. Both companies are clients of RedChip, an investor relations, media, and research firm specializing in microcap and small-cap companies.

    Yahoo! Finance Canada•8/7/26•
    Bullish

    Transcode Therapeutics Inc (RNAZ) Stock News Today

    This article provides current stock information for Transcode Therapeutics Inc (RNAZ), including its real-time price, market cap, and a note that more news is coming soon. As of the close on August 7th, the stock was trading at $3.960 USD, down 3.88%. The platform, TradingKey, offers general investment information but does not provide financial advice.

    TradingKey•8/7/26•
    Bearish

    Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV

    Virax Biolabs Group Ltd. (Nasdaq: VRAX) and Transcode Therapeutics Inc. (Nasdaq: RNAZ) will have interviews aired on the RedChip Small Stocks, Big Money™ show. The program will be broadcast on Bloomberg TV on Saturday, August 8th, at 7:00 p.m. ET, and on CNBC on Sunday, August 9th, at 11:00 a.m. ET. The interviews will cover Virax Biolabs' financial and strategic positioning, and Transcode Therapeutics' evolution into a diversified clinical-stage oncology business.

    New Castle News•8/7/26•
    Bullish

    Frequently Asked Questions About RNAZ

    Does RNAZ pay dividends?
    Transcode Therapeutics Inc (RNAZ) does not currently pay a regular dividend.
    What is RNAZ's market cap?
    Transcode Therapeutics Inc (RNAZ) has a market capitalization of $2.31M with a current stock price of $2.10.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In